Temporal presentation of chronic cancer pain: Transitory pains on admission to a multidisciplinary pain clinic

被引:70
作者
Petzke, F [1 ]
Radbruch, L [1 ]
Zech, D [1 ]
Loick, G [1 ]
Grond, S [1 ]
机构
[1] Univ Cologne, Klin Anasthesiol & Operat Intens Med, Dept Anesthesiol & Operat Intens Care, D-50924 Cologne, Germany
关键词
cancer pain assessment; temporal variations; transitory pain; breakthrough pain; survey;
D O I
10.1016/S0885-3924(99)00023-8
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Transitory flares of pain are well-recognized events in both untreated and treated patients suffering from chronic cancer pain. For the purpose of this survey, we refer to transitory pain (TP) as any event subjectively characterized by transience and pain intensity over a baseline pain. In Part I, TP was reported by 243 (39%) of 613 consecutive cancer pain patients. Gender, age, tumor site, stage, and therapy were not related to the presence of TP Neuropathic baseline pain was associated with a higher prevalence of TP (P < 0.0001). TP was somatic in 39%, visceral in 22%, and neuropathic in 36% of patients. TP intensity was sever or worse in 92% of patients. Neuropathic TP was briefer and occurred more frequently than nociceptive TP? In Part II, further features of TP were surveyed in 55 patients. Patients reported spontaneous occurrence of TP (40%), a relationship to movement (36%), to the analgesic regimen (35%), to coughing (11%), and to various other factors (18%). Only half of the movement-related TP were predictable. Rescue medication was at least partially effective in 75% of patients. Change in position, rest, diversion, and physiotherapy were commonly employed to alleviate TP This survey outlined a framework to characterize TP that may pi-eve useful to clarify the definition, pathophysiology and prevalence of these pains. J Pain Symptom Manage 1999;17:391-401. (C) U.S. Cancer Pain Relief Committee, 1999.
引用
收藏
页码:391 / 401
页数:11
相关论文
共 30 条
  • [1] Andrejuk T, 1998, ONCOLOGY-NY, V12, P1049
  • [2] [Anonymous], OXFORD TXB PALLITATI
  • [3] [Anonymous], OXFORD TXB PALLIATIV
  • [4] [Anonymous], 1996, CANC PAIN REL GUID O
  • [5] TREATMENT OUTCOME IN A MULTIDISCIPLINARY CANCER PAIN CLINIC
    BANNING, A
    SJOGREN, P
    HENRIKSEN, H
    [J]. PAIN, 1991, 47 (02) : 129 - 134
  • [6] Cleary JF, 1997, SEMIN ONCOL, V24, P13
  • [7] PAIN MEASUREMENT IN CANCER-PATIENTS - A COMPARISON OF 6 METHODS
    DECONNO, F
    CARACENI, A
    GAMBA, A
    MARIANI, L
    ABBATTISTA, A
    BRUNELLI, C
    LAMURA, A
    VENTAFRIDDA, V
    [J]. PAIN, 1994, 57 (02) : 161 - 166
  • [8] FARRAR J, 1998, J PAIN SYMPTOM MANAG, V15, pS16
  • [9] Oral transmucosal fentanyl citrate: Randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients
    Farrar, JT
    Cleary, J
    Rauck, R
    Busch, M
    Nordbrock, E
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (08): : 611 - 616
  • [10] THE TREATMENT OF CANCER PAIN
    FOLEY, KM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (02) : 84 - 95